Link: [Comments: s1 explains which stock "the stock" in s2 is.]Analysts expect Columbia/HCA's stock to continue to face near-term pressure but said the company will remain a market leader over the long-term .Columbia/HCA lost 4-3/4 to 33 and was the heavily traded issue on the New York Stock Exchange .Chiarelli said he continues to rate the stock as a buy .NEW YORK 1997-03-31 While shares of Columbia/HCA Healthcare Corp took a beating Monday following a federal probe and media reports about its billing practices , industry analysts continued to support the stock .Anyone who is selling will probably regret it long-term , _" said Brian Eisenbarth , an analyst with Collins & Co .Columbia/HCA said it was not given the opportunity to review the New York Times' data and could not address the newspaper's findings ."_ What would make me uncomfortable is if the government went into other markets and locations at Columbia .The stock is still good long-term .The stock will rebound , but I expect continued negative commentary to pressure the stock for the near-term , _" John Hindelong , an analyst with Donaldson , Lufkin & Jenrette .